EarningsQ4 2022 Earnings Report

Jazz Pharmaceuticals (JAZZN) Q4 2022 Earnings Report

0 Followers

MX:JAZZN Q4 2022 EPS Results

Actual EPS-$1.28

Consensus EPS$16.12

Beat/MissMissed by -$17.40

One Year Ago EPS$76.85

Actual Revenue$17.75B

Expected Revenue$17.81B

Beat/MissMissed by -$61.23M

YoY Revenue Growth+8.41%

QuarterQ4 2022

Date03/01/2023

TimeAfter Close

Conference CallWednesday, March 1, 2023

MX:JAZZN Upcoming Earnings

Jazz Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:JAZZN Q4 2022 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	115.02 / -	148.409	―
Aug 03, 2026	2026 (Q2)	112.72 / 104.23	-150.6	169.21% (+254.83)
May 05, 2026	2026 (Q1)	84.72 / 115.73	30.668	277.38% (+85.07)
Feb 24, 2026	2025 (Q4)	118.98 / 121.21	120.48	0.61% (+0.73)
Nov 05, 2025	2025 (Q3)	108.54 / 148.41	120.662	23.00% (+27.75)
Aug 05, 2025	2025 (Q2)	-138.84 / -150.60	96.749	-255.66% (-247.35)
May 06, 2025	2025 (Q1)	85.03 / 30.67	48.922	-37.31% (-18.25)
Feb 25, 2025	2024 (Q4)	107.01 / 120.48	91.638	31.47% (+28.84)
Nov 06, 2024	2024 (Q3)	100.36 / 120.66	88.352	36.57% (+32.31)
Jul 31, 2024	2024 (Q2)	89.85 / 96.75	82.328	17.52% (+14.42)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed